| 臺大學術典藏 |
2022-03-10T02:31:39Z |
Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy
|
PO-HAN LIN; Yeh M.-H.; Liu L.-C.; Chen C.-J.; Tsui Y.-C.; Su C.-H.; Wang H.-C.; Liang J.-A.; Chang H.-W.; Wu H.-S.; Yeh S.-P.; Li L.-Y.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:39Z |
OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis
|
Bai L.-Y.; Weng J.-R.; Chiu C.-F.; Wu C.-Y.; Yeh S.-P.; Sargeant A.M.; PO-HAN LIN; Liao Y.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation
|
Yeh S.-P.; Lo W.-C.; Hsieh C.-Y.; Bai L.-Y.; Lin C.-C.; PO-HAN LIN; Lin C.-Y.; Liao Y.-M.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer
|
Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
|
Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
|
Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:36Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
Chiang Y.-C.; PO-HAN LIN; Lu T.-P.; Kuo K.-T.; Tai Y.-J.; Hsu H.-C.; Wu C.-Y.; Lee C.-Y.; Shen H.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T02:31:34Z |
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
|
Chiang Y.-C.; PO-HAN LIN; Cheng W.-F. |
| 臺大學術典藏 |
2022-03-10T02:31:33Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
PO-HAN LIN; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2021-12-14T23:12:34Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
PO-HAN LIN; Wang, Ming Yang; Lo, Chiao; Tsai, Li Wei; Yen, Tzu Chun; Huang, Thomas Yoyan; Huang, Wei Chih; Yang, Karen; Chen, Chih Kai; Fan, Sheng Chih; SUNG-HSIN KUO; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-10-21T23:28:15Z |
A dna damage response gene panel for different histologic types of epithelial ovarian carcinomas and their outcomes
|
YING-CHENG CHIANG; PO-HAN LIN; TZU-PIN LU; KUAN-TING KUO; YI-JOU TAI; Hsu, Heng Cheng; Wu, Chia Ying; Lee, Chia Yi; Shen, Hung; CHI-AN CHEN; WEN-FANG CHENG |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer
|
Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S. |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-06-03T06:15:36Z |
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
|
Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN; Tseng L.-M. |
| 臺大學術典藏 |
2021-06-03T06:15:36Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
PO-HAN LIN; Li H.-Y.; Fan S.-C.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T.; Ni Y.-H.; Chiu C.-F. |
| 臺大學術典藏 |
2021-06-03T06:15:35Z |
Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer
|
Po-Han Lin;Chen M.;Tsai L.-W.;Lo C.;Yen T.-C.;Huang T.Y.;Chen C.-K.;Fan S.-C.;Kuo S.-H.;Huang C.-S.; PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-06-03T06:15:35Z |
Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
|
Kwong A.; Ho J.C.W.; Shin V.Y.; Kurian A.W.; Tai E.; Esserman L.J.; Weitzel J.N.; PO-HAN LIN; Field M.; Domchek S.M.; Lo J.; Ngan H.Y.S.; Ma E.S.K.; Chan T.L.; Ford J.M. |
